Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis
Posted by Alimentary Pharmacology & Therapeutics Volume 19, Issue 7, pages 739–747, April 2004 on 4/1/2004 to Accredited Articles
-The Simple Clinical Colitis Activity Index and histological scores decreased significantly during treatment with aloe vera. -Oral aloe vera taken for 4 weeks produced a clinical response more often than placebo; it also reduced the histological disease activity and appeared to be safe. Further evaluation of the therapeutic potential of aloe vera gel in inflammatory bowel disease is needed.